Financial News
Pfizer seeks emergency authorization for COVID-19 booster in children ages 5 to 11
April 27, 2022 at 05:51 AM EDT
Pfizer-BioNTech submitted an application to the U.S. Food and Drug Administration Tuesday, seeking emergency approval for children ages 5 to 11 to receive COVID-19 vaccine boosters.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
